Review of Evans, Biomolecular NMR Spectroscopy

Por Mayo, Kevin H.
Publicado em 1996

NMR Solution Structure of the Angiostatic Peptide Anginex

Por Arroyo, Monica M., Mayo, Kevin H.
Publicado em 2007

The α-galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain

Por Miller, Michelle C, Klyosov, Anatole, Mayo, Kevin H
Publicado em 2009

Structural features for α-galactomannan binding to galectin-1

Por Miller, Michelle C, Klyosov, Anatole A, Mayo, Kevin H
Publicado em 2012

Comparison of (13)C(α)H and (15)NH backbone dynamics in protein GB1

Por Idiyatullin, Djaudat, Nesmelova, Irina, Daragan, Vladimir A., Mayo, Kevin H.
Publicado em 2003

CXC and CC Chemokines Form Mixed Heterodimers: ASSOCIATION FREE ENERGIES FROM MOLECULAR DYNAMICS SIMULATIONS AND EXPERIMENTAL CORRELATIONS

Por Nesmelova, Irina V., Sham, Yuk, Gao, Jiali, Mayo, Kevin H.
Publicado em 2008

Protein lysine-Nζ alkylation and O-phosphorylation mediated by DTT-generated reactive oxygen species

Por Kumar, Nigam, Ippel, Hans, Weber, Christian, Hackeng, Tilman, Mayo, Kevin H
Publicado em 2013

Acylation of SC4 dodecapeptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains.

Por Lockwood, Nathan A, Haseman, Judith R, Tirrell, Matthew V, Mayo, Kevin H
Publicado em 2004

The carbohydrate-binding domain on galectin-1 is more extensive for a complex glycan than for simple saccharides: implications for galectin–glycan interactions at the cell surface...

Por Miller, Michelle C., Nesmelova, Irina V., Platt, David, Klyosov, Anatole, Mayo, Kevin H.
Publicado em 2009

Bacterial membrane disrupting dodecapeptide SC4 improves survival of mice challenged with Pseudomonas aeruginosa

Por Dings, Ruud P.M., Haseman, Judith R., Leslie, Dan B., Luong, Mike, Dunn, David L., Mayo, Kevin H.
Publicado no Biochim Biophys Acta (2013)

Binding of polysaccharides to human galectin-3 at a noncanonical site in its carbohydrate recognition domain

Por Miller, Michelle C, Ippel, Hans, Suylen, Dennis, Klyosov, Anatole A, Traber, Peter G, Hackeng, Tilman, Mayo, Kevin H
Publicado no Glycobiology (2016)

Tumour thermotolerance, a physiological phenomenon involving vessel normalisation

Por Dings, Ruud P.M., Loren, Melissa L., Zhang, Yan, Mikkelson, Sterling, Mayo, Kevin H., Corry, Peter, Griffin, Robert J.
Publicado em 2011

Structure-Based Optimization of Angiostatic Agent 6DBF7, an Allosteric Antagonist of Galectin-1

Por Dings, Ruud P. M., Kumar, Nigam, Miller, Michelle C., Loren, Melissa, Rangwala, Huzaifa, Hoye, Thomas R., Mayo, Kevin H.
Publicado em 2013

Scheduling of Radiation with Angiogenesis Inhibitors Anginex and Avastin Improves Therapeutic Outcome via Vessel Normalization

Por Dings, Ruud P.M., Loren, Melissa, Heun, Hanke, McNiel, Elizabeth, Griffioen, Arjan W., Mayo, Kevin H., Griffin, Robert J.
Publicado em 2007

TOPOMIMETICS OF AMPHIPATHIC β-SHEET AND HELIX-FORMING BACTERICIDAL PEPTIDES NEUTRALIZE LIPOPOLYSACCHARIDE ENDOTOXINS

Por Chen, Xuemei, Dings, Ruud P.M., Nesmelova, Irina, Debbert, Stefan, Haseman, Judith R., Maxwell, Jacques, Hoye, Thomas R., Mayo, Kevin H.
Publicado no J Med Chem (2006)

Probing Functional Heteromeric Chemokine Protein–Protein Interactions through Conformation‐Assisted Oxime Ligation

Por Agten, Stijn M., Koenen, Rory R., Ippel, Hans, Eckardt, Veit, von Hundelshausen, Philipp, Mayo, Kevin H., Weber, Christian, Hackeng, Tilman M.
Publicado no Angew Chem Int Ed Engl (2016)

Beta-sheet is the bioactive conformation of the anti-angiogenic anginex peptide.

Por Dings, Ruud P M, Arroyo, Monica M, Lockwood, Nathan A, van Eijk, Loes I, Haseman, Judy R, Griffioen, Arjan W, Mayo, Kevin H
Publicado em 2003

Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven

Por Dings, Ruud P.M., Van Laar, Emily S., Webber, Jeremy, Zhang, Yan, Griffin, Robert J., Waters, Stephen J., MacDonald, John R., Mayo, Kevin H.
Publicado em 2008

Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer

Por Dings, Ruud P. M., Levine, Joseph I., Brown, Susan G., Astorgues-Xerri, Lucile, MacDonald, John R., Hoye, Thomas R., Raymond, Eric, Mayo, Kevin H.
Publicado no Invest New Drugs (2013)

Anti-tumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding

Por Dings, Ruud P.M., Miller, Michelle C., Nesmelova, Irina, Astorgues-Xerri, Lucile, Kumar, Nigam, Serova, Maria, Chen, Xuimei, Raymond, Eric, Hoye, Thomas R., Mayo, Kevin H.
Publicado no J Med Chem (2012)